FDA Form 483 Response: What to Write and When
Form FDA 483, Inspectional Observations, is the list an FDA investigator leaves at the close of an inspection. It records conditions the investigator judged to be objectionable under the Federal Food, Drug, and Cosmetic Act.
It is one investigator's observations, written for your management to act on, and neither a final agency determination nor a citation of a regulation. The response to it is the last point at which the record is still yours to shape.
The 15 business day window
FDA reviews a response received within 15 business days of the 483 being issued before it decides whether to issue a Warning Letter. Respond later and the agency will ordinarily proceed without waiting for you.
Count business days from the date the 483 was issued, not the date it reached your quality unit. FDA does not expect the work finished in that time, only committed to in writing, with dates.
Answering each observation
Take each observation separately and cover:
- The immediate correction. What you did about the specific instance the investigator saw. Product quarantined, batch rejected, procedure suspended.
- Root cause. Why it happened. An observation answered with a correction and no cause reads as a company that has not looked.
- The systemic action. Where else the same cause could produce the same failure, and what you are changing there. This decides whether the observation recurs at the next inspection.
- Evidence and dates. Attach what exists. For what does not exist yet, give a target date for a named milestone.
Give a date rather than "in Q3". A quarter reads as an estimate; a date reads as a plan someone has resourced.
Common mistakes
Arguing the observation. You may disagree, and there is a way to say so, but a response whose first move is to dispute the investigator's judgement rarely ends the matter.
Correcting the instance only. The investigator saw one batch record. FDA wants to know what your batch records look like generally.
Promising a CAPA with no owner. Commitments are read back to you at the next inspection. Investigators commonly return within 6 to 18 months and ask for evidence that what you committed to was completed on the date you gave.
Silence on the hard one. An unanswered observation is the one that gets quoted in the Warning Letter.
Inspection classification
The investigator files an Establishment Inspection Report and the district classifies the inspection:
- NAI, no action indicated.
- VAI, voluntary action indicated. Objectionable conditions, but not at a level warranting formal action.
- OAI, official action indicated. This is the classification that precedes a Warning Letter, an import alert, or in the worst case a consent decree.
Your response is read as part of that classification.
Frequently asked questions
Is a Form 483 public?
FDA discloses 483s under FOIA, and many are posted or requested by third parties. Assume anything you write will eventually be read by a partner or an acquirer performing diligence.
Do I have to respond at all?
There is no regulation compelling a response. Not responding removes your only chance to influence what FDA does next, so in practice you respond.
What if I cannot fix it in 15 business days?
Submit within the window anyway. An initial response with a plan and dated milestones, followed by progress updates, is the expected pattern.
Does responding stop a Warning Letter?
No. It gives FDA the chance to conclude that one is unnecessary. A response that shows a credible systemic fix is the strongest argument available.
Is a 483 the same as a Warning Letter?
No. A 483 is an investigator's observation list. A Warning Letter is a center or district statement that FDA considers you in violation, and it names the regulations.